Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15

Original Research

Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry

       
Total article views   HTML views PDF downloads Totals
8,658 Dovepress* 7,678+ 670 8,348
PubMed Central* 980 309 1,289
Totals 8,658 979 9,637
*Since 3 December 2020

View citations on PubMed and Google Scholar